Trial NCT05107856

View at ClinicalTrials.gov 
Org. Study IDs: PRT1419-03

Last trial update was posted on 2024-01-31

MeSH Interventions

Azacitidine Venetoclax

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid Leukemia, Myeloid Leukemia, Myeloid, Acute Leukemia, Myelomonocytic, Chronic Leukemia, Myelomonocytic, Juvenile Lymphoma Lymphoma, B-Cell Lymphoma, B-Cell, Marginal Zone Lymphoma, Follicular Lymphoma, Mantle-Cell Lymphoma, Non-Hodgkin Myelodysplastic Syndromes Myeloproliferative Disorders Neoplasms Preleukemia

Other Conditions

Acute Myeloid Leukemia B-cell Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Chronic Myelomonocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Myeloproliferative Neoplasm Small Lymphocytic Lymphoma

Stopping Reasons

Company Decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID